Methods For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis

Patent No. EP2287192 (titled "Methods For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis") was filed by Novartis Vaccines And Diagnostics on Nov 17, 2003. The application was issued on Aug 26, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2287192

NOVARTIS VACCINES AND DIAGNOSTICS
Application Number
EP10178225A
Filing Date
Nov 17, 2003
Status
Revoked
Nov 30, 2018
Publication Date
Aug 26, 2015